Protalix BioTherapeutics Inc - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

International Graphite (ASX: IG6) strikes European graphite processing JV with Italian chemical group ALKEEMIA at Porto Marghera

Representative image of Infosys’ Bengaluru headquarters, highlighting its AI-driven IT services leadership and large deal momentum in Q1 FY26.

Infosys agrees to acquire Optimum Healthcare IT for $465m in its second-largest deal, targeting AI-led transformation of US provider market

MGM Resorts International launches all-inclusive Las Vegas Strip package as resort operators chase value-conscious travel demand

The Las Vegas Strip just got a pricing experiment, and MGM Resorts International is betting guests will notice

Representative image of Asia’s fuel crisis deepening as the Philippines declares an energy emergency after Strait of Hormuz shipping disruptions raised fears over regional oil supply and fuel availability.

Asia’s fuel crisis deepens: Philippines declares emergency as Strait of Hormuz shipping collapses

Read More

5 minute read

Pharma Industry News

EMA moves Protalix (PLX) closer to extended dosing approval for Elfabrio in Fabry disease

Protalix BioTherapeutics secures EMA panel backing for monthly Elfabrio dosing in Fabry disease, unlocking a $25M milestone. See what it means for PLX.

byPallavi Madhiraju

February 1, 2026

web analytics